P-204: In-class transition (iCT) from parenteral bortezomib to oral ixazomib therapy in newly diagnosed multiple myeloma (NDMM) patients (pts): fully accrued data from the communitybased US MM-6 study
Title:
P-204: In-class transition (iCT) from parenteral bortezomib to oral ixazomib therapy in newly diagnosed multiple myeloma (NDMM) patients (pts): fully accrued data from the communitybased US MM-6 study
Author:
Yimer, Habte Birhiray, Ruemu Boccia, Ralph Manda, Sudhir Kambhampati, Suman Richter, Joshua Aiello, Jack Girnius, Saulius Cherepanov, Dasha Tran, Kim Whidden, Presley Noga, Stephen Rifkin, Robert